This startup develops AI-powered diagnostic devices for early detection of cardiovascular diseases, specifically focusing on rheumatic heart disease. Their system analyzes heart sounds to provide rapid diagnoses, enabling timely preventative action for patients.
Funding
Funding not disclosed
Founders
Product
Problem
Rheumatic heart disease, a preventable condition, still causes an estimated 300,000 deaths each year globally due to limitations in access to early detection capabilities, particularly in underserved communities. The lack of accessible diagnostic tools and medical expertise in remote areas contributes to delayed diagnoses and preventable deaths.
Solution
Sonorus AU develops AI-powered diagnostic hardware designed for early detection of rheumatic heart disease, focusing on deployment in areas with limited access to medical expertise. Their system leverages AI to analyze heart sounds, providing rapid and reliable diagnoses. By empowering communities with accessible diagnostic tools, Sonorus aims to connect individuals to early treatment and reduce the number of deaths caused by rheumatic heart disease. The company is currently focused on collecting data to improve the accuracy and confidence of its AI-driven diagnostic system.
Target Audience
The primary target audience includes individuals in underserved communities with limited access to medical expertise, as well as healthcare providers and organizations working to combat rheumatic heart disease in these regions.
Features
- AI-powered analysis of heart sounds for rheumatic heart disease detection
- Portable hardware designed for deployment in remote and underserved communities
- Data collection initiative to continuously improve the AI diagnostic capabilities